home / stock / mrna / mrna news


MRNA News and Press, Moderna Inc. From 06/07/24

Stock Information

Company Name: Moderna Inc.
Stock Symbol: MRNA
Market: NASDAQ
Website: modernatx.com

Menu

MRNA MRNA Quote MRNA Short MRNA News MRNA Articles MRNA Message Board
Get MRNA Alerts

News, Short Squeeze, Breakout and More Instantly...

MRNA - The Hunt for Virus Treatments Continues Post Covid-19

2024-06-07 10:10:00 ET June 7, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform, releases the second of a two-part series looking at news and developments for the treatment of viruses, featuring Aethlon Medical, Inc. (Nasdaq: AEMD ), a medical the...

MRNA - Moderna, Inc. (MRNA) Jefferies 2024 Global Healthcare Conference (Transcript)

2024-06-06 20:46:04 ET Moderna, Inc. (MRNA) Jefferies 2024 Global Healthcare Conference June 6, 2024 10:00 AM ET Company Participants Jamey Mock - CFO Conference Call Participants Michael Yee - Jefferies Presentation Michael Yee [Starts Ab...

MRNA - Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program

2024-06-06 10:13:02 ET More on Moderna Moderna: Betting On Bird Flu Rally Is A Poor Strategy For A Value Investor Bird flu death in Mexico linked to strain not seen in humans before FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall Moderna...

MRNA - ASCO 2024 Round-Up: Some Of The Most Impactful Cancer News Out Of The Big Meeting

2024-06-06 09:07:10 ET Summary AstraZeneca PLC showcased projects in two plenary lecture presentations at the Annual Meeting of the American Society of Clinical Oncology, or ASCO, including a trial that established osimertinib as the standard of care for EGFR-mutant NSCLC. Bristol...

MRNA - Novavax marketing application for COVID shot undergoes FDA review

2024-06-06 08:04:56 ET More on Sanofi, Novavax, etc. Novavax: Sanofi Partnership Revitalizes My Magnum Opus Novavax, Inc. (NVAX) Q1 2024 Earnings Call Transcript Novavax Ditches 'Going Concern,' Embraces Sanofi Safety Net (Rating Upgrade) Bird flu death in Me...

MRNA - Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program

Center for Biologics Evaluation and Research has chosen mRNA-3705 as one of four investigational medicines for accelerated development to address unmet medical needs for rare diseases CAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Foo...

MRNA - Bird flu death in Mexico linked to strain not seen in humans before

2024-06-05 16:48:37 ET More on GSK, Moderna, etc. GSK plc: Long-Term Cash Cow FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall COVID vaccine makers ready updated shots for fall immunization drive Moderna, Inc. (MRNA) Moderna Oncology Inve...

MRNA - FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall

2024-06-05 16:30:31 ET More on vaccine makers Pfizer: The Chart Looks Like A Bottom, But Is The Dividend Safe? COVID vaccine makers ready updated shots for fall immunization drive Pfizer data for breast cancer therapy sends Olema higher Moderna, Inc. (MRNA) M...

MRNA - COVID vaccine makers ready updated shots for fall immunization drive

2024-06-05 10:52:27 ET More on BioNTech, Moderna, etc. Moderna, Inc. (MRNA) Moderna Oncology Investor Event (Transcript) Moderna, Inc. (MRNA) Bernstein's 40th Annual Strategic Decisions Conference (Transcript) Pfizer: The Chart Looks Like A Bottom, But Is The Dividen...

MRNA - Monthly Newsletter - May 2024

2024-06-05 05:10:00 ET Summary High vacancies, increasing taxes and utilities and heavy debt loads are causing some property owners to simply walk away from significant buildings. Pfizer rose to $61 in December 2020 shortly after its vaccine came to market; it now looks decidedly ...

Previous 10 Next 10